235 related articles for article (PubMed ID: 7453855)
1. Immunological studies in breast cancer. Modifying activity of the serum (MSA).
Cervantes C; Muzio E; Exposito G; Garcia ME
Neoplasma; 1980; 27(4):379-86. PubMed ID: 7453855
[TBL] [Abstract][Full Text] [Related]
2. Assessment of cellular immune response to cancer of the breast.
Herberman RB
Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte migration inhibition in relation to nuclear pleomorphism and lymphoid infiltration in breast cancer.
Egami H; Sakamoto K; Kimura M; Nishimura R; Akagi M
Jpn J Clin Oncol; 1985 Jun; 15(2):393-401. PubMed ID: 2410639
[TBL] [Abstract][Full Text] [Related]
4. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
5. Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers.
Black MM; Zachrau RE; Dion AS; Shore B; Fine DL; Leis HP; Williams CJ
Cancer Res; 1976 Nov; 36(11 Pt 1):4137-42. PubMed ID: 184925
[TBL] [Abstract][Full Text] [Related]
6. Immunological monitoring in lung cancer: use of the leukocyte migration inhibition assay.
Abai AM; Fekete B
Haematologia (Budap); 1982; 15(1):111-25. PubMed ID: 6749608
[TBL] [Abstract][Full Text] [Related]
7. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
[TBL] [Abstract][Full Text] [Related]
8. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
Rudczynski AB; Dyer CA; Mortensen RF
Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
[No Abstract] [Full Text] [Related]
9. Peripheral leukocyte migration inhibition reactivity to breast cancer antigens in patients with breast cancer and in normal controls.
Brandes LJ; Goldenberg GJ
Cancer Res; 1976 Oct; 36(10):3707-10. PubMed ID: 953996
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH
J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
12. Detection of a breast tissue-associated antigen by antiserum to Raji cell-bound circulating immune complexes of human breast cancer.
Koestler TP; Papsidero LD; Nemoto T; Chu TM
Cancer Res; 1981 Jul; 41(7):2900-7. PubMed ID: 7018673
[TBL] [Abstract][Full Text] [Related]
13. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
Grosser N; Thomson DM
Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
[TBL] [Abstract][Full Text] [Related]
14. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
15. Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
Cochran AJ; Spilg WG; Mackie RM; Thomas CE
Br Med J; 1972 Oct; 4(5832):67-70. PubMed ID: 5077468
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human hepatoma.
Lee C; Chen S; Lin T
Cancer Res; 1977 Mar; 37(3):918-21. PubMed ID: 189919
[TBL] [Abstract][Full Text] [Related]
17. Detection of mammary serum antigen in sera from breast cancer patients using monoclonal antibody 3E1.2.
Stacker SA; Thompson CH; Sacks NP; Tjandra J; Lowe MG; Bishop J; McKenzie IF
Cancer Res; 1988 Dec; 48(24 Pt 1):7060-6. PubMed ID: 3191482
[TBL] [Abstract][Full Text] [Related]
18. Mammary serum antigen (MSA) levels as a marker for breast cancer: a survey of blood donors and patients with cancer.
Stacker SA; Thompson CH; Lowe MG; Sacks NP; Golder J; Carmen H; McKenzie IF
Dev Biol Stand; 1987; 67():91-6. PubMed ID: 3609486
[TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immunity to mouse mammary tumor virus antigens by patients with hyperplastic benign breast disease.
Cannon GB; Barsky SH; Alford TC; Jerome LF; Tinley V; McCoy JL; Dean JH
J Natl Cancer Inst; 1982 Jun; 68(6):935-43. PubMed ID: 6283226
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patients.
Kovarík J; Lauerová L; Feit J; Ninger E; Munzarová M; Zemanová D; Hlávková J
Cancer Detect Prev; 1983; 6(1-2):215-9. PubMed ID: 6349799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
